Concert Pharmaceuticals, Inc. (CNCE) Social Stream
CONCERT PHARMACEUTICALS INC (CNCE) Price Targets From Analysts
Use the tables below to see what analysts covering CONCERT PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-10 | 1 | $22 | $9 | $14.25 | $8.37 | 70.25% |
2022-03-04 | 3 | $22 | $9 | $14.375 | $8.37 | 71.74% |
2022-05-06 | 4 | $22 | $9 | $14.375 | $8.37 | 71.74% |
2022-08-05 | 4 | $22 | $9 | $15.5 | $8.37 | 85.19% |
2022-09-13 | 4 | $25 | $9 | $16.25 | $8.37 | 94.15% |
2022-11-08 | 3 | $25 | $15 | $19 | $8.37 | 127% |
2023-01-19 | 2 | $17 | $9 | $11.666 | $8.37 | 39.38% |
The Trend in the Analyst Price Target
CNCE's average price target has moved down $3.66 over the prior 18 months.
CNCE reports an average of 203.35% for its upside potential over the past 39 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-04-22 | 4 | 22 | 9 | 14.375 | 3.10 | 363.71% |
2022-09-13 | 3 | 25 | 14 | 18.666 | 6.99 | 167.04% |
2022-11-08 | 3 | 25 | 15 | 19.000 | 4.46 | 326.01% |
2023-01-19 | 2 | 17 | 9 | 11.666 | 8.29 | 40.72% |
2023-01-19 | 3 | 17 | 9 | 11.666 | 8.29 | 40.72% |
CNCE Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 44 weeks, CNCE's average broker recommendation rating worsened by 0.67.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how CONCERT PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 194.9% of that group.
- In terms of how CONCERT PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is greater than 273.64% of that group.
- To contextualize these metrics, consider that out of all US stocks, CONCERT PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1094.4% of them.
- In the context of Pharmaceutical Products stocks, CONCERT PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 536.69% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CONCERT PHARMACEUTICALS INC are CARA, SESN, and TRVN.
View All Top Stocks by Price Target
Make investment decisions regarding CNCE using the data that counts. Try POWR Ratings for free.